Mark Corrigan

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Mark Corrigan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Corrigan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Wave Life Sciences Ltd. Director Ordinary Shares 28,815 $405,282 $14.06 08 Dec 2025 Direct
Nabriva Therapeutics plc Director Ordinary Shares 7,203 $10,805 $1.50 02 Aug 2022 Direct
Wave Life Sciences Ltd. Director Share Option (right to buy) 76,200 11 Aug 2025 Direct
TREVENA INC Director Stock Option (Right to Buy) 13,700 13 Jun 2024 Direct
TREVENA INC Director No securities beneficially owned 0 18 Jul 2023 Direct

Insider Reports Filed by Mark Corrigan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
WVE Wave Life Sciences Ltd. 08 Dec 2025 2 -$217,297 4 Director 10 Dec 2025, 21:45
WVE Wave Life Sciences Ltd. 11 Aug 2025 2 $0 4 Director 13 Aug 2025, 20:00
WVE Wave Life Sciences Ltd. 12 Aug 2024 2 $0 4 Director 14 Aug 2024, 18:00
TRVN TREVENA INC 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 17:39
WVE Wave Life Sciences Ltd. 07 Aug 2023 1 $0 4 Director 09 Aug 2023, 20:00
TRVN TREVENA INC 18 Jul 2023 1 $0 4 Director 20 Jul 2023, 20:51
TRVN TREVENA INC 18 Jul 2023 0 $0 3 Director 20 Jul 2023, 20:50
WVE Wave Life Sciences Ltd. 15 Aug 2022 1 $0 4 Director 17 Aug 2022, 20:00
/report/000110465922086277-corrigan-mark-2022-08-02 Nabriva Therapeutics plc 02 Aug 2022 1 -$1,956 4 Director 04 Aug 2022, 18:19
WVE Wave Life Sciences Ltd. 16 Aug 2021 1 $0 4 Director 18 Aug 2021, 18:09
/report/000110465921098423-corrigan-mark-2021-07-28 Nabriva Therapeutics plc 28 Jul 2021 2 $0 4 Director 30 Jul 2021, 20:18
/report/000110465921077205-corrigan-mark-2021-06-02 Nabriva Therapeutics plc 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 17:50
/report/000110465921077199-corrigan-mark-2021-06-02 Nabriva Therapeutics plc 02 Jun 2021 0 $0 3 Director 04 Jun 2021, 17:47